Literature DB >> 10950774

Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens.

A E Bryant1, R Y Chen, Y Nagata, Y Wang, C H Lee, S Finegold, P H Guth, D L Stevens.   

Abstract

Mechanisms responsible for the rapid tissue destruction in gas gangrene are not well understood. To examine the early effects of Clostridium perfringens exotoxins on tissue perfusion, a rat model of muscle blood flow was developed. Intramuscular injection of a clostridial toxin preparation containing both phospholipase C (PLC) and theta-toxin caused a rapid (1-2 min) and irreversible decrease in blood flow that paralleled formation of activated platelet aggregates in venules and arterioles. Later (20-40 min), aggregates contained fibrin and leukocytes, and neutrophils accumulated along vascular walls. Flow cytometry confirmed that these clostridial toxins or recombinant PLC induced formation of P-selectin-positive platelet aggregates. Neutralization of PLC activity in the clostridial toxin preparation completely abrogated human platelet responses and reduced perfusion deficits. It is concluded that tissue destruction in gas gangrene is related to profound attenuation of blood flow initiated by activation of platelet responses by PLC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10950774     DOI: 10.1086/315756

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Clostridium sordellii phospholipase C: gene cloning and comparison of enzymatic and biological activities with those of Clostridium perfringens and Clostridium bifermentans phospholipase C.

Authors:  Tadahiro Karasawa; Xingmin Wang; Tsuneo Maegawa; Yoshio Michiwa; Hiroyuki Kita; Koichi Miwa; Shinichi Nakamura
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

2.  Membrane vesicles of Clostridium perfringens type A strains induce innate and adaptive immunity.

Authors:  Yanlong Jiang; Qingke Kong; Kenneth L Roland; Roy Curtiss
Journal:  Int J Med Microbiol       Date:  2014-02-19       Impact factor: 3.473

3.  Combination bacteriolytic therapy for the treatment of experimental tumors.

Authors:  L H Dang; C Bettegowda; D L Huso; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

Review 4.  Bacterial Sphingomyelinases and Phospholipases as Virulence Factors.

Authors:  Marietta Flores-Díaz; Laura Monturiol-Gross; Claire Naylor; Alberto Alape-Girón; Antje Flieger
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-15       Impact factor: 11.056

5.  Clostridial myonecrosis: new insights in pathogenesis and management.

Authors:  Amy E Bryant; Dennis L Stevens
Journal:  Curr Infect Dis Rep       Date:  2010-09       Impact factor: 3.725

6.  Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues.

Authors:  David K O'Brien; Stephen B Melville
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 7.  Biology and pathogenesis of thrombosis and procoagulant activity in invasive infections caused by group A streptococci and Clostridium perfringens.

Authors:  Amy E Bryant
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

8.  Staphylococcus aureus α-hemolysin promotes platelet-neutrophil aggregate formation.

Authors:  Tanyalak Parimon; Zhi Li; Devin D Bolz; Eric R McIndoo; Clifford R Bayer; Dennis L Stevens; Amy E Bryant
Journal:  J Infect Dis       Date:  2013-05-22       Impact factor: 5.226

Review 9.  Toxin plasmids of Clostridium perfringens.

Authors:  Jihong Li; Vicki Adams; Trudi L Bannam; Kazuaki Miyamoto; Jorge P Garcia; Francisco A Uzal; Julian I Rood; Bruce A McClane
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

10.  BEC, a novel enterotoxin of Clostridium perfringens found in human clinical isolates from acute gastroenteritis outbreaks.

Authors:  Shinya Yonogi; Shigeaki Matsuda; Takao Kawai; Tomoko Yoda; Tetsuya Harada; Yuko Kumeda; Kazuyoshi Gotoh; Hirotaka Hiyoshi; Shota Nakamura; Toshio Kodama; Tetsuya Iida
Journal:  Infect Immun       Date:  2014-03-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.